Ontology highlight
ABSTRACT:
SUBMITTER: Liu D
PROVIDER: S-EPMC6368716 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
Liu Delong D Zhao Juanjuan J Song Yongping Y Luo Xiaofeng X Yang Ting T
Journal of hematology & oncology 20190208 1
The relapse rate remains high after chemotherapy for adult patients with acute lymphoblastic leukemia (ALL). With better molecular diagnosis and classification as well as better assessment for minimal residual disease, major progress in the treatment for refractory and/or relapsed ALL is being made. In addition to the tyrosine kinase inhibitors (TKIs) for Philadelphia chromosome-positive ALL, immunotherapeutic agents, blinatumomab, inotuzumab ozogamicin (INO), and chimeric antigen receptor (CAR) ...[more]